Awareness-Raising Event in the Pharmaceutical and Medical Fields: “Living with Illness. Living with Hope. Photo Exhibition: ~Toward a Future That Creates Answers We Have Yet to Discover~” In collaboration with four organizations, we are hosting a photo exhibition featuring works by Mr. Herbie Yamaguchi
November 20, 2023
The Japan Pharmaceutical Manufacturers Association (Chairman: Hiroaki Ueno; hereinafter “JPMA”), in collaboration with the Japan Society of Clinical Oncology (a public interest incorporated association),the Japan Cancer Society (General Incorporated Association), the Japanese Society for Cancer Therapy (General Incorporated Association), and CancerX (General Incorporated Association), will host a photography exhibition titleda photography exhibition titled “Living with Illness. Living with Hope. Photography Exhibition: Toward a Future That Creates Answers Yet to Be Found” (hereinafter referred to as “this exhibition”) at sorama gallery (Jingumae, Shibuya-ku, Tokyo) from Tuesday, December 12, 2023, to Sunday, December 17, 2023.
Even with today’s advanced medical care, challenges such as “unmet medical needs”—including cases where no treatment has been found, no effective drugs have been developed, or where treatment imposes a significant burden—as well as issues known as “drug lag/loss,” where drugs approved overseas are not approved in Japan or are not even being developed here, still exist.JPMA aims to raise public awareness of these issues and increase the number of people who support efforts to resolve them.
November is designated by the Ministry of Health, Labor and Welfare as “Month for Thinking About Healthcare Together.”Organized in collaboration with four partner organizations, this photo exhibition features portraits and messages from patients facing illness, their families, cancer survivors, supporters, and healthcare professionals—people from diverse backgrounds who are battling illness without losing hope.
Furthermore, the portraits in this exhibition were taken by photographer Harvie Yamaguchi, whose work consistently centers on the theme of “capturing the hope of life.”
Through this photo exhibition, the JPMA will continue to contribute to raising awareness and promoting understanding of social issues in the pharmaceutical and medical fields.
Purpose of the Exhibition
In the society in which we live, there are people who face their illnesses day by day, believing that the day will come when they can use the medication they desire or when a cure will be found.For this photo exhibition, we have received cooperation from people in various roles—including patients and their families, cancer survivors, those involved in patient support activities, as well as doctors, nurses, and pharmacists—to showcase, through photographs and messages, their resilience and hope as they live with illness.In conjunction with the exhibition, we plan to publish an introduction to this photo exhibition on the Japan Pharmaceutical Manufacturers Association website:
. We hope to raise awareness among the many people who are not directly affected by these issues regarding the challenges facing the pharmaceutical and medical fields, and to encourage a shift from indifference to concern and from misunderstanding to understanding.
Exhibition Overview
| Dates | December 12, 2023 (Tue) – December 17, 2023 (Sun)
|
|---|---|
| Hours
| 10:00 a.m.–7:00 p.m. (3:00 p.m.–7:00 p.m. on December 12 only; scheduled to end at 5:00 p.m. on December 17)
|
| Venue | sorama gallery Address: 1st Floor, Dohi Building, 1-12-6 Jingumae, Shibuya-ku, Tokyo Links: http://sorama.tokyo/gallery/access/ Access: 3-minute walk from Meiji-Jingumae Station; 5-minute walk from Harajuku Station |
| Admission Fee | Free |
| Organizer | Japan Pharmaceutical Manufacturers Association |
| In Cooperation With | Japan Society of Clinical Oncology (Public Interest Incorporated Association), Japanese Cancer Association (General Incorporated Association), Japanese Society for Cancer Therapy (General Incorporated Association), CancerX (General Incorporated Association) |
<Profile of Mr. Harvey Yamaguchi>
Born in Tokyo in 1950. After graduating from university, he moved to London in 1973 and spent 10 years there. While in London, he acted with a theater troupe and, at the same time, encountered the emerging punk rock and new wave movements, experiencing one of the most exciting eras in London’s history.Since returning to Japan, he has turned his camera on many domestic artists—including Masaharu Fukuyama, Koji Yoshikawa, and Yutaka Ozaki—as well as ordinary people, creating a body of work characterized by monochrome snapshot portraits. Drawing on his experience of suffering from a long-term illness called caries during his childhood and adolescence, he has defined the theme of his photography as “capturing the hope of life.”He has many fans who appreciate his gentle and refined style, and he enjoys support from a wide range of age groups.
In addition to photography, he writes essays, hosts radio shows, and gives lectures; he has also written lyrics for several songs by guitarist Tomoyasu Hotei.
Her major works include “LONDON AFTER THE DREAM,” “Daikanyama 17,” “HOPE: The Sky Turns Blue,” “What Makes a Good Photograph,” and “Photographs That Bring Happiness.”
Her pen name, “Harvey,” is derived from the jazz flutist Harvey Mann, whom she deeply admires.
Awards: 2011 Japan Photographic Society Artist Award.
Visiting Professor at Osaka University of Arts.
Harvey Yamaguchi
Organization Overview
Japan Pharmaceutical Manufacturers Association (JPMA)
The JPMA is a voluntary association comprising 71 research-and-development-oriented pharmaceutical companies (as of October 1, 2023).Established in 1968, the JPMA has contributed to global healthcare through the development of groundbreaking new prescription drugs, guided by its motto of “Realizing Patient-Centered Healthcare.”The JPMA carries out multifaceted initiatives, including addressing common issues facing the pharmaceutical industry, promoting a deeper understanding of pharmaceuticals, and fostering international collaboration. Furthermore, the
association
is committed to the sound development of the pharmaceutical industry, particularly through strengthening policy formulation and advocacy, responding to globalization, and enhancing public relations efforts.Japan Society of Clinical Oncology (Public Interest Incorporated Association
)The Japanese Society of Clinical Oncology is an organization established in 1993 with the goals of establishing medical oncology (internal oncology and clinical oncology) and promoting clinical research and clinical trials in cancer treatment. Currently operating as a Public Interest Incorporated Association, it is one of the sub-sections of the Japan Medical Association and has 8,900 members.The Society trains and certifies “Specialists in Cancer Chemotherapy”—experts in anticancer drugs who possess knowledge and skills in drug therapy for a wide range of cancers—and disseminates accurate information on cancer treatment and raises awareness among healthcare professionals and the general public through educational programs and public lectures.
Japanese Society of Clinical Oncology official website: https://www.jsmo.or.jp/
Japan Cancer Society (General Incorporated Association)
The Japan Cancer Society was established in 1941. It is an academic organization dedicated to “contributing to the health and welfare of the public” by “advancing cancer research,” with a membership of approximately 14,000 (as of November 2023).Japanese Cancer Society official website:
https://www.cancer.or.jp/ Japan Society for Cancer Therapy (General Incorporated Association )
The Japan Society for Cancer Therapy was established in 1963. With 16,304 members (as of the end of July 2023), it is Japan’s largest academic organization specializing in cancer.It is a society where various healthcare professionals and researchers involved in cancer prevention, diagnosis, and treatment gather to identify current challenges in cancer care and research and discuss the future together. The society is also committed to activities aimed at realizing a society where cancer patients and their families can live with peace of mind and safety.Japanese Society for Cancer Therapy official website: https://www.jsco.or.jp/
General Incorporated Association CancerX CancerX
is an organization where people from diverse backgrounds—including industry, academia, government, the private sector, and the medical community—join forces to tackle societal challenges related to cancer. It has been active as a member of the UICC (Union for International Cancer Control) since 2020.CancerX official website: https://cancerx.jp/